198 related articles for article (PubMed ID: 35256729)
1. TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.
Park DW; Kim YJ; Sung YK; Chung SJ; Yeo Y; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Sohn JW
Sci Rep; 2022 Mar; 12(1):4003. PubMed ID: 35256729
[TBL] [Abstract][Full Text] [Related]
2. Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study.
Park HJ; Choi B; Song YK; Oh YJ; Lee EB; Kim IW; Oh JM
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002613
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area.
Liao TL; Lin CF; Chen YM; Liu HJ; Chen DY
Sci Rep; 2016 Jul; 6():29443. PubMed ID: 27404002
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data.
Jung SM; Kwok SK; Ju JH; Park YB; Park SH
Korean J Intern Med; 2019 May; 34(3):669-677. PubMed ID: 29172405
[TBL] [Abstract][Full Text] [Related]
5. Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea.
Lim DH; Kim YG; Shim TS; Jo KW; Ghang B; Ahn SM; Hong S; Lee CK; Yoo B
Korean J Intern Med; 2017 Nov; 32(6):1090-1097. PubMed ID: 28063416
[TBL] [Abstract][Full Text] [Related]
6. One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
Lim CH; Lin CH; Chen DY; Chen YM; Chao WC; Liao TL; Chen HH
PLoS One; 2016; 11(11):e0166339. PubMed ID: 27832150
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study.
Takei H; Nishina N; Namkoong H; Suzuki K; Uwamino Y; Hasegawa N; Takeuchi T
Mod Rheumatol; 2022 Apr; 32(3):534-540. PubMed ID: 34910202
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis and Nontuberculous Mycobacterial Infections in Patients with Spondyloarthritis: A Population-Based Study.
Yang J; Jang HA; Cho H; Im YH; Kim JH
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674225
[No Abstract] [Full Text] [Related]
9. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study.
Choi SR; Shin A; Ha YJ; Lee YJ; Lee EB; Kang EH
Arthritis Res Ther; 2023 Jul; 25(1):129. PubMed ID: 37495973
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of mycobacterial infections associated with anti-rheumatic medications.
Brode SK; Jamieson FB; Ng R; Campitelli MA; Kwong JC; Paterson JM; Li P; Marchand-Austin A; Bombardier C; Marras TK
Thorax; 2015 Jul; 70(7):677-82. PubMed ID: 25911222
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis.
Kwak N; Moon J; Kim JY; Park JW; Yim JJ
Adv Rheumatol; 2024 Mar; 64(1):20. PubMed ID: 38491558
[TBL] [Abstract][Full Text] [Related]
13. Clinical investigation of nontuberculous mycobacterial lung disease in Japanese patients with rheumatoid arthritis receiving biologic therapy.
Yamakawa H; Takayanagi N; Ishiguro T; Kanauchi T; Hoshi T; Sugita Y
J Rheumatol; 2013 Dec; 40(12):1994-2000. PubMed ID: 24187100
[TBL] [Abstract][Full Text] [Related]
14. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada.
Brode SK; Jamieson FB; Ng R; Campitelli MA; Kwong JC; Paterson JM; Li P; Marchand-Austin A; Bombardier C; Marras TK
Chest; 2014 Sep; 146(3):563-572. PubMed ID: 24384637
[TBL] [Abstract][Full Text] [Related]
15. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.
Ljung L; Askling J; Rantapää-Dahlqvist S; Jacobsson L;
Arthritis Res Ther; 2014 Jun; 16(3):R127. PubMed ID: 24941916
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study.
Rotar Z; Svetina P; Tomsic M; Hočevar A; Prapotnik S
BMJ Open; 2020 Feb; 10(2):e034356. PubMed ID: 32029494
[TBL] [Abstract][Full Text] [Related]
17. Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs).
Paul D; Patil D; McDonald L; Patel V; Lobo F
J Med Econ; 2020 Sep; 23(9):1025-1031. PubMed ID: 32427547
[No Abstract] [Full Text] [Related]
18. The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.
Conti F; Atzeni F; Massaro L; Chiara Gerardi M; Gremese E; Passiu G; Carletto A; Malavolta N; Foti R; Ramonda R; Sarzi-Puttini P
Rheumatology (Oxford); 2018 Oct; 57(57 Suppl 7):vii11-vii22. PubMed ID: 30289537
[TBL] [Abstract][Full Text] [Related]
19. Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study.
Shin A; Park EH; Dong YH; Ha YJ; Lee YJ; Lee EB; Song YW; Kang EH
Osteoporos Int; 2020 Nov; 31(11):2131-2139. PubMed ID: 32514765
[TBL] [Abstract][Full Text] [Related]
20. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
